| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |